These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16533809)

  • 1. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure.
    Herbert AP; Uhrín D; Lyon M; Pangburn MK; Barlow PN
    J Biol Chem; 2006 Jun; 281(24):16512-20. PubMed ID: 16533809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
    Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
    J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional characterization of the product of disease-related factor H gene conversion.
    Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
    Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational mini-review series on complement factor H: structural and functional correlations for factor H.
    Schmidt CQ; Herbert AP; Hocking HG; Uhrín D; Barlow PN
    Clin Exp Immunol; 2008 Jan; 151(1):14-24. PubMed ID: 18081691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
    Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
    J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of electrostatics on factor H function and related pathologies.
    Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
    J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
    Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
    J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
    Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
    Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex.
    E S Harrison R; Gorham RD; Morikis D
    Protein Sci; 2015 May; 24(5):789-802. PubMed ID: 25628052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
    Hyvärinen S; Meri S; Jokiranta TS
    Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.
    Pechtl IC; Kavanagh D; McIntosh N; Harris CL; Barlow PN
    J Biol Chem; 2011 Apr; 286(13):11082-90. PubMed ID: 21270465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.
    Morgan HP; Jiang J; Herbert AP; Kavanagh D; Uhrin D; Barlow PN; Hannan JP
    Acta Crystallogr D Biol Crystallogr; 2011 Jul; 67(Pt 7):593-600. PubMed ID: 21697597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.
    Hyvärinen S; Uchida K; Varjosalo M; Jokela R; Jokiranta TS
    J Biol Chem; 2014 Feb; 289(7):4295-306. PubMed ID: 24344133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations.
    Hocking HG; Herbert AP; Kavanagh D; Soares DC; Ferreira VP; Pangburn MK; Uhrín D; Barlow PN
    J Biol Chem; 2008 Apr; 283(14):9475-87. PubMed ID: 18252712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
    Jokiranta TS; Jaakola VP; Lehtinen MJ; Pärepalo M; Meri S; Goldman A
    EMBO J; 2006 Apr; 25(8):1784-94. PubMed ID: 16601698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
    Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
    Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
    Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
    Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
    Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
    J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
    Heinen S; Sanchez-Corral P; Jackson MS; Strain L; Goodship JA; Kemp EJ; Skerka C; Jokiranta TS; Meyers K; Wagner E; Robitaille P; Esparza-Gordillo J; Rodriguez de Cordoba S; Zipfel PF; Goodship TH
    Hum Mutat; 2006 Mar; 27(3):292-3. PubMed ID: 16470555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.